In this study, the opportunities and challenges faced by the Danish pharmaceutical company Novo Nordisk in relation to its sustainable approach in China since 2012. Novo Nordisk is seeking to integrate its activities in the financial, environmental and social responsibility, and many employees of Novo Nordisk is proud to belong to Novo Nordisk, as the "triple bottom line (TBL) company." Novo Nordisk was active in China for more than 50 years, however, as China's economy has expanded enormously, the increase of wealth and more sedentary Western lifestyles have led to the growing problem of obesity. As a result of the insulin market in China is booming. Novo Nordisk therefore facing new challenges on how to better organize your TBL program so that a comprehensive approach throughout the organization, but allows Novo Nordisk China to take the initiative to meet the Chinese business context. In addition, with the increasing competition for access to the lucrative market of insulin in China, rivals Novo Nordisk also participated in the resistance, which means that Novo Nordisk must be innovative in order to stand out, and have to use sustainability as a source of competitive advantage. "Hide
by Jette Steen Knudsen, Dan Brown Source: Richard Ivey School of Business Foundation 17 pages. Publication Date: September 7, 2012. Prod. #: W12186-PDF-ENG
Related Case Solutions & Analyses:
Space Shuttle
Alara Agri: Fresh Cherry Production
Cuba & Kathy Engle
Not So Rosy Situation: Bill Azizs Challenge at White Rose Crafts and Nursery Sales Limited
Finning International: Integrating Hewden Stuart PLC
mGames
Pacific Century Cyberworks (A): Connecting to the World
Bonny Doon Vineyards
Planning the Canadian Introduction of the New Pantene
The Totalline Company
